Can a Biopsy Worsen Tumor Spread? Here's What You Need to Know

With the growing wealth of medical knowledge online, many people turn to the internet for health advice. However, finding conflicting information from experts can create confusion, especially on whether a biopsy might cause cancer cell spread. Let's explore the facts behind this concern and clarify when a biopsy is both necessary and beneficial.

What Is Biopsy and Why Is It Essential?

A biopsy involves extracting a tissue sample from a tumor or suspicious area to analyze it under a microscope. It helps doctors determine whether the tumor is benign or malignant, and if malignant, it allows identification of the cancer type and stage. Despite advanced imaging techniques, a biopsy remains the gold standard for diagnosis.

For instance, a suspected liver tumor in a patient with hepatitis and elevated alpha-fetoprotein (AFP) might point strongly to primary liver cancer. In such cases, additional confirmation with a biopsy may not be necessary, allowing doctors to proceed directly to surgery.

On the other hand, a breast lump that appears cancerous on ultrasound may still require biopsy confirmation. Breast cancer includes several subtypes that affect treatment plans. For example, hormone receptor status and HER2 expression can guide the need for chemotherapy, surgery, radiation, or targeted therapies. In these cases, a biopsy is crucial for creating a precise treatment approach.

Does Biopsy Cause Cancer Spread?

Biopsies occasionally lead to concerns about tumor cell spread, a process known as "needle tract seeding." This occurs when cells are inadvertently dislodged during the biopsy, travel along the needle path, and implant in surrounding tissue. However, studies show that this risk is very low. Data from medical research dating back to the 1990s estimated the risk of needle tract seeding at around 0.003%-0.009%, while some studies in China found rates as high as 2.3% in certain cases. Regardless, even at the higher estimate, the risk remains low relative to the benefits of accurate diagnosis.

Mechanisms Behind Needle Tract Seeding

Several factors contribute to the potential of needle tract seeding:

• Cell Detachment: Tumor cells may adhere to the biopsy needle, and as the needle withdraws, they could transfer to adjacent tissues.
• Multiple Needle Passes: Biopsies requiring multiple angles or sampling points have a slightly higher risk, as repeated needle insertions can increase the chances of cell dissemination.
• Subcapsular Tumors: Cancers that grow near the capsule of organs, such as subcapsular liver cancers, are more prone to cell release upon needle penetration.
• Needle Diameter: Finer needles, such as those used in fine-needle aspiration, carry lower risks, while larger core needles used for more detailed sampling may increase the risk slightly.

Cases When a Biopsy May Not Be Necessary

In specific situations where clinical evidence strongly suggests malignancy, a biopsy may not be required:

• Primary Liver Cancer: For patients with chronic hepatitis, liver cirrhosis, elevated AFP, and imaging consistent with liver cancer, the clinical diagnosis may suffice, allowing doctors to move directly to surgery.
• Breast Cancer: Imaging alone may confirm breast cancer in certain cases, but given the variety of breast cancer subtypes and the need for immunohistochemical analysis, a biopsy is often still recommended.
• Thyroid Nodules: Suspicious thyroid nodules often benefit from biopsy, as the alternative may involve thyroid removal. Since this could require lifelong medication if the nodule turns out to be benign, a biopsy helps patients avoid unnecessary surgery.

▲ Image 1: Fine-needle biopsy procedure for breast cancer diagnosis.

Weighing the Risks and Benefits

Although there is a minimal risk of cancer cell seeding, the benefits of biopsy are undeniable. A biopsy allows for precise diagnosis and, in most cases, guides treatment plans that improve outcomes. Without a biopsy, there is a far greater risk of misdiagnosis, delayed treatment, or inadequate therapeutic measures, all of which can lead to poor outcomes.

Patients should consider the following key points:

• Biopsy Accuracy vs. Risk: Core needle biopsies, though slightly riskier, offer better tissue sampling, improving diagnostic accuracy.
• Treatment Planning: Certain cancers require specific genetic and molecular profiling, which can only be obtained from a biopsy sample. For example, gene tests for breast cancer can determine if chemotherapy or hormonal therapy would be more effective.
• Timing and Treatment: In cases like liver or thyroid cancer, early biopsy can mean faster, more effective treatment.

In general, when a biopsy is recommended by a doctor, it's usually after careful consideration of all factors, including risks and benefits.

Listening to Professional Advice

Whether to proceed with a biopsy can vary greatly depending on individual cases. While it's natural to feel concerned about potential risks, speaking with your healthcare provider is essential to understand the necessity of a biopsy and any specific precautions that may be taken.

▲ Image 2: Doctor discussing biopsy results with a patient.